Literature DB >> 9268945

Ganglioside expression in lung cancer cell lines.

R Fuentes1, R Allman, M D Mason.   

Abstract

Gangliosides are complex glycolipid constituents of cell membranes. They are involved in many biological functions including cell-cell recognition, cell-matrix attachment, cell growth and cell differentiation. Analysis of tumor associated gangliosides may aid in the characterisation of tumour cells and their degree of malignant transformation. We have characterised a total of eight lung cancer cell lines (four small cell and four non-small cell lung cancer) with respect to ganglioside and alpha v integrin receptor expression. Ganglioside GD3 was detected using the monoclonal antibody R24. Ganglioside GM1 was detected using the beta-subunit of cholera toxin. Ganglioside 9-O-acetyl GD3 and the alpha v integrin receptor were measured using commercially available monoclonal antibodies. Our results indicate that small cell lung cancer cell lines express significant levels of GD3 and 9-O-acetyl GD3. Ganglioside GM1 and alpha v integrin receptor were not specific to any histological subtype. The expression of ganglioside GM1 and GD3 was independent of cell-cycle phase. We conclude that GD3 and 9-O-acetyl GD3 expression may be additional markers of the Small Cell Lung Cancer phenotype, but their significance is unknown. Therefore a characteristic ganglioside pattern cannot be defined according to histological subtype. alpha v integrin receptor expression is not unique to cells expressing GD3.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9268945     DOI: 10.1016/s0169-5002(97)00049-4

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  13 in total

1.  Respiratory Homeostasis and Exploitation of the Immune System for Lung Cancer Vaccines.

Authors:  Adam Yagui-Beltrán; Lisa M Coussens; David M Jablons
Journal:  US Oncol       Date:  2009

2.  A General Chemoenzymatic Strategy for the Synthesis of Glycosphingolipids.

Authors:  Yunpeng Liu; Liuqing Wen; Lei Li; Madhusudhan Reddy Gadi; Wanyi Guan; Kenneth Huang; Zhongying Xiao; Mohui Wei; Cheng Ma; Qing Zhang; Hai Yu; Xi Chen; Peng George Wang; Junqiang Fang
Journal:  European J Org Chem       Date:  2016-08-16

Review 3.  Fast, hungry and unstable: finding the Achilles' heel of small-cell lung cancer.

Authors:  Christine L Hann; Charles M Rudin
Journal:  Trends Mol Med       Date:  2007-02-26       Impact factor: 11.951

Review 4.  Immunotherapy in lung cancer.

Authors:  Erminia Massarelli; Vassiliki Papadimitrakopoulou; James Welsh; Chad Tang; Anne S Tsao
Journal:  Transl Lung Cancer Res       Date:  2014-02

Review 5.  Cellular and molecular biology of small cell lung cancer: an overview.

Authors:  Niki Karachaliou; Sara Pilotto; Chiara Lazzari; Emilio Bria; Filippo de Marinis; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2016-02

Review 6.  Cancer stem cells in small cell lung cancer.

Authors:  Jordi Codony-Servat; Alberto Verlicchi; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2016-02

7.  Acetylation suppresses the proapoptotic activity of GD3 ganglioside.

Authors:  Florence Malisan; Luigi Franchi; Barbara Tomassini; Natascia Ventura; Ivano Condò; Maria Rita Rippo; Alessandra Rufini; Laura Liberati; Claudia Nachtigall; Bernhard Kniep; Roberto Testi
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

8.  Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis.

Authors:  Francesca Margheri; Laura Papucci; Nicola Schiavone; Riccardo D'Agostino; Silvana Trigari; Simona Serratì; Anna Laurenzana; Alessio Biagioni; Cristina Luciani; Anastasia Chillà; Elena Andreucci; Tommaso Del Rosso; Giancarlo Margheri; Mario Del Rosso; Gabriella Fibbi
Journal:  J Cell Mol Med       Date:  2014-10-14       Impact factor: 5.310

Review 9.  Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy.

Authors:  Sophie Groux-Degroote; Philippe Delannoy
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

10.  O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia.

Authors:  Reshmi Parameswaran; Min Lim; Anna Arutyunyan; Hisham Abdel-Azim; Christian Hurtz; Kam Lau; Markus Müschen; Robert K Yu; Mark von Itzstein; Nora Heisterkamp; John Groffen
Journal:  J Exp Med       Date:  2013-03-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.